Publikationen, an denen er mitarbeitet JOSÉ LUIS PEDRAZ MUÑOZ (134)

2011

  1. Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 77, Núm. 2, pp. 306-312

  2. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173

2010

  1. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: Level A in vitro-in vivo correlation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 75, Núm. 2, pp. 232-237

  2. Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration

    International Journal of Pharmaceutics, Vol. 385, Núm. 1-2, pp. 157-162

2009

  1. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors

    Journal of Controlled Release, Vol. 133, Núm. 1, pp. 52-59

  2. Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice

    Cancer Chemotherapy and Pharmacology, Vol. 64, Núm. 1, pp. 153-159

  3. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 71, Núm. 2, pp. 181-189

2008

  1. Cationic lipids as gene transfer agents: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 18, Núm. 5, pp. 515-524

  2. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of Kendine 91, a novel histone deacetylase inhibitor, in mice plasma and tissues: Application to a pharmacokinetic study

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 870, Núm. 1, pp. 109-116

  3. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy

    Clinical Pharmacokinetics, Vol. 47, Núm. 3, pp. 173-180

  4. Solid lipid nanoparticles for retinal gene therapy: Transfection and intracellular trafficking in RPE cells

    International Journal of Pharmaceutics, Vol. 360, Núm. 1-2, pp. 177-183

  5. Utilización de antimicrobianos en las infecciones odontogénicas en niños y adolescentes: Análisis farmacocinético/farmacodinámico (PK/PD)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 10, pp. 621-628

2007

  1. In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies

    Chemotherapy, Vol. 53, Núm. 3, pp. 194-201

  2. Proceedings del VIII Congreso de la Sociedad Española de Farmacia Industrial yGalénica

    Leioa : Universidad del País Vasco. Servicio Editorial = Euskal Herriko Unibertsitatea. Argitalpen Zerbitzua, 2007

  3. Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity

    International Journal of Pharmaceutics, Vol. 339, Núm. 1-2, pp. 261-268

2006

  1. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition

    Biomaterials, Vol. 27, Núm. 28, pp. 4831-4839

  2. Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: Evaluation of the sieving coefficient

    Blood Purification, Vol. 24, Núm. 4, pp. 347-354

  3. Evaluation of human serum albumin as a substitute of foetal bovine serum for cell culture

    International Journal of Pharmaceutics, Vol. 310, Núm. 1-2, pp. 8-14

  4. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules

    Journal of Controlled Release, Vol. 116, Núm. 1, pp. 28-34

  5. Terapia génica: concepto, sistemas de administración y aplicaciones

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 128, pp. 86-99